# MONTELUKAST SODIUM
> **ANDA207464** · Abbreviated New Drug Application (Generic) · Sponsor: CHARTWELL MOLECULAR · Approved 2018-12-06
## Drug
- **FDA Application Number:** ANDA207464
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** MONTELUKAST SODIUM
- **Generic name:** Montelukast Sodium
- **Active ingredients:** MONTELUKAST SODIUM
- **Dosage form:** TABLET, CHEWABLE
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CHARTWELL MOLECULAR
- **First approval:** 2018-12-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=207464)
---
*AI Analytics · CC0 1.0*